We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SH icon
3651
ProShares Short S&P500
SH
$914M
$195K ﹤0.01%
+4,497
New +$204K
SLV icon
3652
CALL
iShares Silver Trust
SLV
$27.6B
$195K ﹤0.01%
7,500
-12,700
-63% -$341K
XFLT
3653
XAI Floating Rate & Alternative Income Trust
XFLT
$285M
$194K ﹤0.01%
5,684
+142
+3% +$4.93K
EFC
3654
Ellington Financial
EFC
$1.7B
$193K ﹤0.01%
14,939
+2,172
+17% +$28K
GNL icon
3655
Global Net Lease
GNL
$1.86B
$192K ﹤0.01%
22,842
-5,117
-18% -$43K
MDWD icon
3656
MediWound
MDWD
$188M
$191K ﹤0.01%
+10,593
New +$193K
WEA
3657
Western Asset Premier Bond Fund
WEA
$123M
$191K ﹤0.01%
16,948
IHTA
3658
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$191K ﹤0.01%
25,068
-1,624
-6% -$12.1K
UEIC icon
3659
Universal Electronics
UEIC
$58.1M
$190K ﹤0.01%
20,585
+551
+3% +$5.56K
MMT
3660
Aberdeen Multi-Market Income Fund
MMT
$238M
$190K ﹤0.01%
38,938
-2,047
-5% -$9.75K
DJT icon
3661
Trump Media & Technology Group
DJT
$2.74B
$189K ﹤0.01%
11,749
+1,198
+11% +$29K
ALDX icon
3662
Aldeyra Therapeutics
ALDX
$95.3M
$188K ﹤0.01%
34,884
+251
+0.7% +$1.2K
ASC icon
3663
Ardmore Shipping
ASC
$669M
$188K ﹤0.01%
10,370
-2,926
-22% -$56.4K
BANC icon
3664
Banc of California
BANC
$3.27B
$186K ﹤0.01%
12,632
-970
-7% -$13.5K
RFMZ
3665
RiverNorth Flexible Municipal Income Fund II
RFMZ
$319M
$185K ﹤0.01%
12,791
-2,933
-19% -$41.8K
RC
3666
Ready Capital
RC
$261M
$185K ﹤0.01%
24,245
+3,345
+16% +$28.4K
GRX
3667
Gabelli Healthcare & Wellness Trust
GRX
$145M
$184K ﹤0.01%
16,843
-101
-0.6% -$1.06K
NFLX icon
3668
PUT
Netflix
NFLX
$301B
$183K ﹤0.01%
+3,000
New +$201K
IEP icon
3669
Icahn Enterprises
IEP
$5.26B
$183K ﹤0.01%
13,508
-952
-7% -$14.4K
TGB
3670
Trekor Metals
TGB
$2.52B
$180K ﹤0.01%
71,443
RTX icon
3671
PUT
RTX Corp
RTX
$295B
$180K ﹤0.01%
2,000
CYH icon
3672
Community Health Systems
CYH
$393M
$180K ﹤0.01%
29,625
-120,098
-80% -$589K
PTON icon
3673
Peloton Interactive
PTON
$2.84B
$180K ﹤0.01%
38,373
-1,508
-4% -$5.93K
GERN icon
3674
Geron
GERN
$930M
$178K ﹤0.01%
39,170
+855
+2% +$3.89K
DEA
3675
Easterly Government Properties
DEA
$1.17B
$177K ﹤0.01%
5,226
-52,266
-91% -$1.75M

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.